Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cardiology

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2017.03.154PMID 28476513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding sex differences in the regulation of cancer-induced muscle wasting

  2018cited by this paper
• Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation

  2016cited by this paper
• ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker

  2016cited by this paper
• Impact of creatine supplementation in combination with resistance training on lean mass in the elderly

  2016cited by this paper
• Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling

  2016cited by this paper
• Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario.

  2016cited by this paper
• Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine

  2016cited by this paper
• Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.

  2016cited by this paper
• Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score

  2016cited by this paper
• Body mass index in acute heart failure: association with clinical profile, therapeutic management and in‐hospital outcome

  2016cited by this paper
• Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)

  2016cited by this paper
• A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project

  2016cited by this paper
• Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction

  2015cited by this paper
• Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative

  2015cited by this paper
• Febuxostat improves outcome in a rat model of cancer cachexia

  2015cited by this paper
• Detection of muscle wasting in patients with chronic heart failure using C‐terminal agrin fragment: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF)

  2015cited by this paper
• Rapid screening for sarcopenia

  2015cited by this paper
• Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis

  2015cited by this paper
• Prevalence of sarcopenia among community‐dwelling elderly of a medium‐sized South American city: results of the COMO VAI? study

  2015cited by this paper
• Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin

  2015cited by this paper
• Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

  2015cited by this paper
• Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research

  2015cited by this paper
• Biomarkers for physical frailty and sarcopenia: state of the science and future developments

  2015cited by this paper
• Pathophysiology of anorexia in the cancer cachexia syndrome

  2015cited by this paper
• Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

  2015cited by this paper
• Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review

  2015cited by this paper
• Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle

  2015cited by this paper
• Cachexia: a nutritional syndrome?

  2015cited by this paper
• Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat

  2015cited by this paper
• Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials

  2015cited by this paper
• Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm

  2015cited by this paper
• Ribonucleotide reductase‐mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure

  2015cited by this paper
• ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients

  2015cited by this paper
• Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice

  2015cited by this paper
• Cardiorespiratory fitness and risk of heart failure: a population‐based follow‐up study

  2014cited by this paper
• Cancer cachexia: understanding the molecular basis

  2014cited by this paper
• Sex‐dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload

  2014cited by this paper
• Patients’ rationale for declining participation in a cancer-associated weight loss study

  2014cited by this paper
• Diet-Induced and Age-Related Changes in the Quadriceps Muscle: MRI and MRS in a Rat Model of Sarcopenia

  2014cited by this paper
• Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014

  2014cited by this paper
• Formoterol in the treatment of experimental cancer cachexia: effects on heart function

  2014cited by this paper
• Muscle wasting in disease: molecular mechanisms and promising therapies

  2014cited by this paper
• Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.

  2014cited by this paper
• Uric acid and risk of heart failure: a systematic review and meta‐analysis

  2014cited by this paper
• Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion

  2014cited by this paper
• Effects of exercise training on depression in patients with heart failure: a systematic review and meta‐analysis of randomized controlled trials

  2014cited by this paper
• Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.

  2014cited by this paper
• Sex differences in cardiomyopathies

  2014cited by this paper
• Sarcopenia Prevalence and Associated Factors in an Elderly Taiwanese Metropolitan Population

  2013cited by this paper
• Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact

  2013cited by this paper
• Megestrol acetate for treatment of anorexia-cachexia syndrome.

  2013cited by this paper
• Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.

  2013cited by this paper
• The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

  2013cited by this paper
• Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)

  2013cited by this paper
• Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice

  2013cited by this paper
• Rodent models of heart failure: an updated review

  2013cited by this paper
• Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study.

  2013cited by this paper
• Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort.

  2013cited by this paper
• Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

  2013cited by this paper
• Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

  2012cited by this paper
• Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis.

  2012cited by this paper
• Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia

  2012cited by this paper
• Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass

  2012cited by this paper
• Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial.

  2012cited by this paper
• Analysis of liver metabolism in a rat model of heart failure.

  2012cited by this paper
• Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents

  2012cited by this paper
• Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.

  2011cited by this paper
• Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.

  2011cited by this paper
• Trimetazidine improves exercise performance in patients with peripheral arterial disease.

  2011cited by this paper
• Cancer cachexia and fat-muscle physiology.

  2011cited by this paper
• Sarcopenia with limited mobility: an international consensus.

  2011cited by this paper
• Cardiac Structure and Function and Dependency in the Oldest Old

  2011cited by this paper
• The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

  2011cited by this paper
• Definition and classification of cancer cachexia: an international consensus.

  2011cited by this paper
• Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice.

  2011cited by this paper
• PGC-1 (cid:1) Promotes Nitric Oxide Antioxidant Defenses and Inhibits FOXO Signaling Against Cardiac Cachexia in Mice

  2011cited by this paper
• Progressive resistance strength training for improving physical function in older adults.

  2011cited by this paper
• Sarcopenia - age-related muscle wasting and weakness : mechanisms and treatments

  2011cited by this paper
• Animal models of the cancer anorexia–cachexia syndrome

  2011cited by this paper
• Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure

  2010cited by this paper
• Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

  2010cited by this paper
• Cachexia as a major underestimated and unmet medical need: facts and numbers

  2010cited by this paper
• Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.

  2010cited by this paper
• Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

  2010cited by this paper
• Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

  2010cited by this paper
• Cardiac alterations in cancer-induced cachexia in mice.

  2010cited by this paper
• Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

  2010cited by this paper
• Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey

  2010cited by this paper
• American College of Sports Medicine roundtable on exercise guidelines for cancer survivors.

  2010cited by this paper
• Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.

  2009cited by this paper
• Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice

  2009cited by this paper
• The influence of age and sex on disease development in a novel animal model of cardiac cachexia.

  2009cited by this paper
• Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice

  2009cited by this paper
• No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.

  2009cited by this paper
• Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.

  2008cited by this paper
• Prevalence, severity and underdiagnosis of COPD in the primary care setting

  2008cited by this paper
• ACE inhibitors for sarcopenia--as good as exercise training?

  2008cited by this paper
• Cachexia: a new definition.

  2008cited by this paper
• Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.

  2008cited by this paper

• Unravelling rheumatoid arthritis-related sarcopenia: animal models, pathogenesis, and anti-sarcopenia preclinical therapy

  2025cites this paper
• The convergence of two epidemics – unravelling the diagnostic complexities at the heart of cardio‐oncology

  2025cites this paper
• Cardiac wasting in patients with advanced cancer: state of the art review

  2025cites this paper
• Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.

  2022cites this paper
• In Vitro Model of Human Skeletal Muscle Tissue for the Study of Resident Macrophages and Stem Cells

  2022cites this paper
• To Synthesize Hydroxyapatite by Modified Low Temperature Method Loaded with Bletilla striata Polysaccharide as Antioxidant for the Prevention of Sarcopenia by Intramuscular Administration

  2021cites this paper
• Skeletal Muscle Specific Calpastatin Overexpression Mitigates Muscle Weakness in Aging and Extends Lifespan.

  2021cites this paper
• Curcumin-Loaded Hydrophobic Surface-Modified Hydroxyapatite as an Antioxidant for Sarcopenia Prevention

  2021cites this paper
• The eccentric mechanotransduction, neuro-muscular transmission, and structural reversibility of muscle fatty infiltration. An experimental advanced disuse muscle-wasting model of rabbit supraspinatus

  2021cites this paper
• A Pound of Flesh: What Cachexia Is and What It Is Not

  2021cites this paper
• Unraveling the Links Underlying Arterial Stiffness, Bone Demineralization, and Muscle Loss

  2020cites this paper
• Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.

  2020cites this paper
• How progressive cancer endangers the heart: an intriguing and underestimated problem

  2020cites this paper
• Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach

  2020cites this paper
• Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia

  2020cites this paper
• Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

  2020cites this paper
• A Method for Precision Surgical Implantation and Probe Insertion in Sprague-Dawley Rat Brain

  2020cites this paper
• Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes

  2019cites this paper
• Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line

  2019cites this paper
• Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition

  2019cites this paper
• Cachexia and Sarcopenia in Companion Animals: An Under‐Utilized Natural Animal Model of Human Disease

  2018cites this paper
• Cardiac expression of neutrophil gelatinase‐associated lipocalin in a model of cancer cachexia‐induced cardiomyopathy

  2018cites this paper
• Understanding sex differences in the regulation of cancer-induced muscle wasting

  2018cites this paper
• Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice

  2018cites this paper
• Collagen‐induced arthritis as an animal model of rheumatoid cachexia

  2018cites this paper
• Evaluation of the effect of cholesterol supplementation on experimental pulmonary arterial hypertension

  2018cites this paper
• Establishment and characterization of a novel murine model of pancreatic cancer cachexia

  2017cites this paper